Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Bausch Health Companies (NYSE/TSX: BHC) has announced its participation in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida. The event is scheduled for Monday, February 24, 2025, at 8:45 a.m. EST.
The company will provide a live audio webcast of the event, which will be accessible through the Investor Relations section of Bausch Health's website. Interested parties can access the webcast at http://ir.bauschhealth.com/events-and-presentations. A replay of the event will be made available on the same investor relations website after the conference.
Bausch Health Companies (NYSE/TSX: BHC) ha annunciato la sua partecipazione alla 2025 J.P. Morgan Global Leveraged Finance Conference a Miami Beach, Florida. L'evento è programmato per lunedì 24 febbraio 2025, alle 8:45 a.m. EST.
La società fornirà un webcast audio in diretta dell'evento, accessibile tramite la sezione Relazioni con gli Investitori del sito web di Bausch Health. Le parti interessate possono accedere al webcast su http://ir.bauschhealth.com/events-and-presentations. Una registrazione dell'evento sarà disponibile sullo stesso sito web delle relazioni con gli investitori dopo la conferenza.
Bausch Health Companies (NYSE/TSX: BHC) ha anunciado su participación en la 2025 J.P. Morgan Global Leveraged Finance Conference en Miami Beach, Florida. El evento está programado para el lunes 24 de febrero de 2025, a las 8:45 a.m. EST.
La compañía ofrecerá un webcast de audio en vivo del evento, que será accesible a través de la sección de Relaciones con Inversores del sitio web de Bausch Health. Las partes interesadas pueden acceder al webcast en http://ir.bauschhealth.com/events-and-presentations. Una repetición del evento estará disponible en el mismo sitio web de relaciones con inversores después de la conferencia.
바우쉬 헬스 컴퍼니즈 (NYSE/TSX: BHC)는 플로리다 마이애미 비치에서 열리는 2025 J.P. 모건 글로벌 레버리지 파이낸스 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2025년 2월 24일 월요일 오전 8시 45분 EST에 예정되어 있습니다.
회사는 이벤트의 실시간 오디오 웹캐스트를 제공할 예정이며, 이는 바우쉬 헬스 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있습니다. 관심 있는 분들은 http://ir.bauschhealth.com/events-and-presentations에서 웹캐스트에 접속할 수 있습니다. 이벤트의 재생은 컨퍼런스 후 동일한 투자자 관계 웹사이트에서 제공될 예정입니다.
Bausch Health Companies (NYSE/TSX: BHC) a annoncé sa participation à la 2025 J.P. Morgan Global Leveraged Finance Conference à Miami Beach, en Floride. L'événement est prévu pour le lundi 24 février 2025, à 8h45 EST.
L'entreprise fournira un webcast audio en direct de l'événement, qui sera accessible via la section Relations avec les Investisseurs du site Web de Bausch Health. Les parties intéressées peuvent accéder au webcast à l'adresse http://ir.bauschhealth.com/events-and-presentations. Un enregistrement de l'événement sera disponible sur le même site de relations avec les investisseurs après la conférence.
Bausch Health Companies (NYSE/TSX: BHC) hat seine Teilnahme an der 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida, bekannt gegeben. Die Veranstaltung ist für Montag, den 24. Februar 2025, um 8:45 Uhr EST angesetzt.
Das Unternehmen wird einen Live-Audio-Webcast der Veranstaltung bereitstellen, der über den Bereich Investor Relations auf der Website von Bausch Health zugänglich sein wird. Interessierte Parteien können den Webcast unter http://ir.bauschhealth.com/events-and-presentations abrufen. Eine Wiederholung der Veranstaltung wird nach der Konferenz auf derselben Investor-Relations-Website verfügbar sein.
- None.
- None.
LAVAL, QC / ACCESS Newswire / February 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.
Details
Date: |
| Monday, February 24, 2025 |
Time: |
| 8:45 a.m. U.S. EST |
Webcast: |
|
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact: |
| Media Contact: |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
FAQ
When is Bausch Health (BHC) presenting at the 2025 J.P. Morgan Conference?
How can investors access BHC's J.P. Morgan Conference presentation?
Will there be a replay available of BHC's 2025 J.P. Morgan Conference presentation?
Which stock exchanges is BHC listed on according to the announcement?
